V
Vikas Chandhoke
Researcher at George Mason University
Publications - 57
Citations - 3098
Vikas Chandhoke is an academic researcher from George Mason University. The author has contributed to research in topics: Fatty liver & Adipose tissue. The author has an hindex of 27, co-authored 56 publications receiving 2860 citations. Previous affiliations of Vikas Chandhoke include Inova Fairfax Hospital & Colby College.
Papers
More filters
Journal ArticleDOI
Adipokines and cytokines in non-alcoholic fatty liver disease
Mohammed Jarrar,Ancha Baranova,Ancha Baranova,Ancha Baranova,R. Collantes,Benjamin L. Ranard,Maria Stepanova,C. Bennett,Yun Fang,Hazem Elariny,Zachary Goodman,Vikas Chandhoke,Vikas Chandhoke,Zobair M. Younossi,Zobair M. Younossi,Zobair M. Younossi +15 more
TL;DR: A small number of adipocytokines have been implicated in the pathogenesis of non‐alcoholic fatty liver disease (NAFLD) and these drugs were found to have an anti-inflammatory effect on mice with NAFLD.
Journal ArticleDOI
Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients
Janus P. Ong,Hazem Elariny,Rochelle Collantes,Abraham Younoszai,Vikas Chandhoke,H David Reines,Zachary Goodman,Zobair M. Younossi +7 more
TL;DR: NAFLD and NASH are very common in morbidly obese patients undergoing bariatric surgery and features associated with the metabolic syndrome and liver cell injury are independently associated with either NASH or advanced fibrosis.
Journal ArticleDOI
A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).
Zobair M. Younossi,Zobair M. Younossi,Zobair M. Younossi,Mohammed Jarrar,Mohammed Jarrar,Clare Nugent,Clare Nugent,Manpreet Randhawa,Manpreet Randhawa,Mariam Afendy,Mariam Afendy,Maria Stepanova,Maria Stepanova,Nila Rafiq,Nila Rafiq,Zachary Goodman,Vikas Chandhoke,Vikas Chandhoke,Ancha Baranova,Ancha Baranova,Ancha Baranova +20 more
TL;DR: Four ELISA-based tests were combined to form a simple diagnostic biomarker for NASH and blinded validation of this model confirmed its reliability for separating NASH from simple steatosis.
Journal ArticleDOI
A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease
Zobair M. Younossi,Zobair M. Younossi,Ancha Baranova,Katharine Ziegler,Luca Del Giacco,Karen Schlauch,Karen Schlauch,Timothy L. Born,Hazem Elariny,Francesco Gorreta,Amy VanMeter,Abraham Younoszai,Janus P. Ong,Janus P. Ong,Zachary Goodman,Vikas Chandhoke +15 more
TL;DR: Analysis of hepatic gene expression and serum protein content in patients with different subtypes of NAFLD suggests differential expression of several genes and protein peaks in patients within and across the forms ofNAFLD.
Journal ArticleDOI
Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease.
Michael Estep,D. Armistead,D. Armistead,Noreen Hossain,H. Elarainy,Zachary Goodman,Ancha Baranova,Ancha Baranova,Vikas Chandhoke,Zobair M. Younossi,Zobair M. Younossi,Zobair M. Younossi +11 more
TL;DR: Aliment Pharmacol Ther 2010; 32: 487–497